Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17
Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information.
View Original Alert
Important: This alert is aggregated automatically for information only.
Always refer to the original source and follow your practice's own clinical governance procedures.
About this source
Alerts and Recalls for Drugs and Medical Devices - All
All alerts from this source
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest